TrialTrials2024

A placebo-controlled, crossover trial to investigate the efficacy of tiotropium bromide or placebo added to usual care in stable symptomatic post-hematopoietic stem cell transplantation (HSCT) bronchiolitis obliterans syndrome (BOS).

Naeemeh Dini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.